Actavis, Forest Labs Give Up 4 Generics In FTC Settlement
Pharmaceutical companies Actavis PLC and Forest Laboratories Inc. will sell or give up their rights to four generic drugs to settle the Federal Trade Commission's allegations that Actavis' $25 billion purchase...To view the full article, register now.
Already a subscriber? Click here to view full article